Harvard Apparatus Regenerative Technology Reports Third Quarter 2023 Financial Results Holliston, MA, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) (“Harvard Apparatus Regenerative Technology” or the “Company”), a clinical-stage...

Spherix Global Insights Announces New Leadership to Drive Growth and Innovation Exton, Pennsylvania, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Spherix Global Insights, a leading provider of market data and insights to the pharmaceutical industry, is thrilled to announce the appointment...

Blue Water Biotech Collaborates with IQVIA to Build Medical Sales Representative Team to Market Commercial Product Portfolio CINCINNATI, June 21, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”) (Nasdaq: BWV), a biotechnology and pharmaceutical company spanning multiple sectors, today...

Mateon Therapeutics Selects IQVIA for its Randomized, Controlled, Multi-Center Clinical Study to Test OT-101 as a Treatment for COVID-19 Patients AGOURA HILLS, Calif., June 23, 2020 (GLOBE NEWSWIRE) -- Mateon Therapeutics (OTCQB: MATN), a leading developer of TGF-β therapeutics, has selected IQVIA to manage C001, a Phase 2 randomized,...

IQVIA Institute Rates WellDoc’s BlueStar® as “Top App” in Clinical Diabetes Treatment COLUMBIA, Md., Nov. 13, 2017 (GLOBE NEWSWIRE) -- WellDoc®, a leading digital health company, announced today that IQVIA Institute for Human Data Science (formerly Quintiles/IMS) named BlueStar®,...